Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Samuel V. Calzadilla"'
Autor:
Jinshyun R. Wu-Wong, Terry J. Opgenorth, Douglas B. Dixon, Robert J. Padley, Samuel V. Calzadilla, Jerry L. Wessale, Andrew L. Adler
Publikováno v:
Journal of Cardiovascular Pharmacology. 36:S292-S296
Endothelin (ET) receptor antagonists may be beneficial for treating several medical conditions. Human trials with various ET receptor antagonists show that these antagonists elevate the plasma immunoreactive endothelin-1 (irET-1) level, and different
Autor:
Chang Z. Zhu, Robert J. Padley, Terry J. Opgenorth, Samuel V. Calzadilla, Jerry L. Wessale, James J Lynch, Elizabeth A. Kowaluk, Michael F. Jarvis, Brian D. Dayton
Publikováno v:
European Journal of Pharmacology. 388:29-35
Tactile allodynia, the enhanced perception of pain in response to normally non-painful stimulation, represents a common complication of diabetic neuropathy. The activation of endothelin ET(A) receptors has been implicated in diabetes-induced reductio
Autor:
Samuel V. Calzadilla, Douglas B. Dixon, Daniel J. Hoffman, Brian D. Dayton, Hugh N. Nellans, Lisa E. Hernandez, William J. Chiou, Jinshyun R. Wu-Wong, Kennan C. Marsh, Kester Jeffrey A, T. J. Opgenorth, T. W. Von Geldern
Publikováno v:
Journal of Medicinal Chemistry. 39:982-991
The oral absorption profile of a family of azole-based ET(A)-selective antagonists has been improved through a rational series of structural modifications which were suggested by analysis of the physicochemical parameter delta log P. Comparison of ur
Publikováno v:
American Journal of Hypertension. 6:514-521
A-72517 is a potent inhibitor of human renin (IC50 = 1.0 nmol/L, pH 7.4 in plasma) and, aside from displaying modest activity against canine plasma renin (IC50 = 110 nmol/L), has been shown to be orally active in the dog and other animals. Renin inhi
Autor:
Glenn A. Reinhart, Bryan F. Cox, C. Thomas Lin, Samuel V. Calzadilla, Ryan M. Fryer, Hongyu Xu, Lee C. Preusser, Murali Gopalakrishnan, Yanhui Hu, Kennan C. Marsh
Publikováno v:
Journal of cardiovascular pharmacology. 44(2)
The therapeutic utility of K A T P channel opening agents (KCOs) in the treatment of overactive bladder may be limited by hypotension as a result of insufficient selectivity in vivo for bladder versus vasculature smooth muscle. Recently, we demonstra
Autor:
Kennan C. Marsh, Terry J. Opgenorth, Brian D. Dayton, J. Ruth Wu-Wong, Thomas W. von Geldern, Martin Winn, Andrew L. Adler, Jerry L. Wessale, Eugene I. Novosad, Jae Hwan-Soo, Samuel V. Calzadilla
Publikováno v:
Clinical science (London, England : 1979). 103
Endothelins (ETs), 21-amino-acid peptides involved in the pathogenesis of various diseases, bind to ETA and ETB receptors to initiate their effects. Based on the same core structure, we have developed four small-molecule ET receptor antagonists, ABT-
Autor:
Jerry L. Wessale, William J. Chiou, Kennan C. Marsh, Bruce G. Szczepankiewicz, Thomas W. von Geldern, Eugene I. Novosad, Lisa M. Hernández, Jinshyun R. Wu-Wong, Gang Liu, Samuel V. Calzadilla, Douglas B. Dixon, Andrew L. Adler, Brian D. Dayton, Terry J. Opgenorth
Publikováno v:
European journal of pharmacology. 366(2-3)
Endothelins, 21-amino acid peptides involved in the pathogenesis of various diseases, bind to endothelin ETA and ETB receptors to initiate their effects. Here, we characterize the pharmacology of A-216546 ([2S-(2,2-dimethylpentyl)-4S-(7-methoxy-1,3-b
Autor:
Samuel V. Calzadilla, Vered Klinghofer, Boyd Steven A, Peter J. Kovar, William R. Baker, Jerry L. Wessale, Herman H. Stein, Jennifer L. Barlow, Robert A. Mantei, Hollis D. Kleinert
Publikováno v:
Journal of cardiovascular pharmacology. 22(4)
A-74273 is a nonpeptidic, potent inhibitor of human and canine renin (IC50 = 3.1 and 43 nM, respectively, in plasma at pH 7.4) and has been shown to be orally active in dogs. To determine the hemodynamic mechanism underlying this renin inhibitor's hy
Publikováno v:
Cardiovascular research. 12(11)
Abrupt coronary occlusion was performed in anaesthetised, open-chest dogs with pre-occlusion arterial blood P o2 ranging from 8.0 to 10.7 kPa (60 to 80 mmHg). Ventricular fibrillation occurred in 15/19 dogs with high spontaneous heart rate (greater t
Autor:
Robert D. Reynolds, Samuel V. Calzadilla, Dennis E. Drayer, William E. Burmeister, Robert J. Lee, Marcus M. Reidenberg
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 169(2)
The antiarrhythmic effects of p-hydroxy-N-(3-diethylaminopropyl)benzamide (PP), procainamide (PA), and N-acetylprocainamide (NAPA) were compared. ED50 values for PP, PA, and NAPA in the mouse chloroform arrhythmia model were not significantly differe